MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0012697
Sanjeevan Drugs Private Limited
Sanjeevan Drugs Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.98 Cr
▲ 21% YoY
Net profit · FY 2025
₹45.03 Lakh
Net margin 9%
EBITDA · FY 2025
₹93.79 Lakh
EBITDA margin 18.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.05 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
26 yrs
Est. 2000
Directors on board
2
As per MCA filings
About Sanjeevan Drugs Private Limited
Data last updated:
Sanjeevan Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 17 August 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL2000PTC107325. Its GSTIN is 07AAHCS5257R1ZJ (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.05 Lakh. It is led by directors Meghna Aggarwal Singhania and Anita Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4868/24 Ansari Roaddarya Ganj, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.98 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹45.03 Lakh (net margin 9%) and EBITDA of ₹93.79 Lakh (EBITDA margin 18.8%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
Sanjeevan Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0012697). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33119DL2000PTC107325
Registration Number 107325
Incorporation Date 17 August 2000
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0012697
Recognitions & Rankings of Sanjeevan Drugs
Contact details
Sanjeevan Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address4868/24 Ansari Roaddarya Ganj, New Delhi, Delhi, India – 110002
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Sanjeevan Drugs Private Limited, buy the company report.
Comprehensive company report
Sanjeevan Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Sanjeevan Drugs are trade and hospital and medical care. In detail, this covers retail trading and other hospital and medical care activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sanjeevan Drugs Private Limited, buy the company report.
Financials of Sanjeevan Drugs Private Limited
FY 2025 filings availableSanjeevan Drugs Private Limited reported revenue of ₹4.98 Cr (up 21% YoY) for FY 2025.
Revenue · FY 2025
₹4.98 Cr ▲ 21%
Net profit · FY 2025
₹45.03 Lakh margin 9%
EBITDA · FY 2025
₹93.79 Lakh margin 18.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 6%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 93%
3 years · compounded
▲ 91%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 21% growth in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹93.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.8% | ||||
| Net Profit Margin | 9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanjeevan Drugs Private Limited, buy the company report.
Board of directors of Sanjeevan Drugs Private Limited
Sanjeevan Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meghna Aggarwal Singhania | Director | 02 May 2011 | 15 Years 5 Months | Current |
| Anita Aggarwal | Director | 17 Aug 2000 | 26 Years 2 Months | Current |
Auditor
Sanjeevan Drugs Private Limited is audited by SINGH K V GUPTA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH K V GUPTA & CO | FY 2023 | 000133N |
Shareholding
The shareholding of Sanjeevan Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanjeevan Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2011 | 10313438 | Allahbad Bank | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sanjeevan Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanjeevan Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sanjeevan Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCS5257R1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sanjeevan Drugs Private Limited, buy the company report.
Recent activity
Sanjeevan Drugs Private Limited has 3 board changes on record since 2000: 2 appointments and 1 cessation. The latest: Prem Aggarwal ceased to be Managing Director on 01 Apr 2020.
AGM
Sanjeevan Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sanjeevan Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Prem Aggarwal ceased to be Managing Director.
Charges
A charge with Allahbad Bank amounted to Rs. 40.00 Lakh with Charge ID 10313438 was registered on 29 Sep 2011.
Appointed
Meghna Aggarwal Singhania was appointed as Director.
Appointed
Anita Aggarwal was appointed as Director.
Incorporation
17 Aug 2000
Sanjeevan Drugs Private Limited was registered on 17 Aug 2000 with Roc Delhi & aged 26 years 2 months as per MCA records.
Frequently asked questions
Sanjeevan Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 17 August 2000 (26+ years old) and is registered under CIN U33119DL2000PTC107325.
Sanjeevan Drugs has 2 current directors:
- Meghna Aggarwal Singhania - Director
- Anita Aggarwal - Director
The latest financial statements of Sanjeevan Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sanjeevan Drugs is 07AAHCS5257R1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Sanjeevan Drugs is U33119DL2000PTC107325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanjeevan Drugs was incorporated on 17 August 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
Prem Aggarwal ceased to be Managing Director on 01 Apr 2020. Meghna Aggarwal Singhania was appointed as Director on 02 May 2011. Anita Aggarwal was appointed as Director on 17 Aug 2000.
Yes, Sanjeevan Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0012697).
The registered office of Sanjeevan Drugs is at 486824 Ansari Roaddarya Ganj, New Delhi, Delhi, India – 110002.
Sanjeevan Drugs operates in the healthcare industry, in the diagnostic centers and pathology labs segment.